Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Q-122 for Vasomotor Symptoms in Breast Cancer Patients
NCT03518138Phase 2Completed
- Sponsor
- QUE Oncology
- Start
- Oct 2018
- Primary completion
- Jul 2020
- Modality
- Small Molecules
- Countries
- 3
01
Overview
A Phase 2 trial of Q-122 in vasomotor symptoms, sponsored by QUE Oncology. Started Oct 2018; status: completed.
02
Drugs
Q-122
03
Conditions
vasomotor symptoms
Beyond the preview
Go deeper on NCT03518138.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT03518138.